A chemical that spurs growth of nerve cells during fetal development may provide a new way to treat severe chronic pain that results from nerve damage, according to a study of rodents.
“Is this a promising candidate for a drug? The answer is, absolutely yes,” says Frank Porreca of the University of Arizona Health Sciences Center in Tucson.
Log in
Subscribers, enter your e-mail address for full access to the Science News archives and digital editions.